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Inflammation and Fibrosis S87Conclusion: miR-214 expression in children with CKD increased significantly,
and miR-214 expression was positively correlated with the severity of pro-
teinuria. It suggested that miR-214 in kidney is associated with tubular injury
during proteinuria.http://dx.doi.org/10.1016/j.hkjn.2015.09.1300329
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Objective: To investigate the role of autophagy in Aldo-induced podocyte
damage and the underlying mechanism.
Methods: Mouse podocytes were treated with Aldo or H2O2 in the presence
or absence of 3-methyladenine (3-MA) and NAC. Cell apoptosis was investi-
gated by detecting Annexin V conjugates, apoptotic bodies, caspase-3 activ-
ity, and the alteration of podocyte protein nephrin. Autophagy was
evaluated by measuring the expressions of LC3, p62, beclin-1 and Atg5 and
evaluating the extent of autophagic flux using ad-mRFP-GFP staining.
Results: Aldo (107 mol/L) induced podocyte apoptosis, autophagy and
downregulation of nephrin protein in a time-dependent manner. After 24
hours of Aldo treatment, the apoptosis rate was increased significantly
(P < 0.05) as compared with control group. After 48 hours of stimulation,
the apoptosis rate was further increased by 41.8%. Nephrin protein expres-
sion was significantly decreased (P < 0.05) with Aldo for 24 hours. Typical
autophagosomes appeared in podocytes 24 hours after aldosterone treat-
ment. Transmission electron microscopy and Ad-mRFP-GFP-LC3 showed
that Aldo induced the formation of autophagosome bodies. Moreover, west-
ern blot analysis demonstrated that the autophagy marker protein LC3-I
(18 kDa) was converted to LC3-II (16 kDa), p62 was decreased and Atg5
was increased in a time-dependent manner after cells were treated with
Aldo. Aldo-induced apoptosis was further promoted by the inhibition of
autophagy via 3-MA and Atg5 siRNA pretreatment. Moreover, Aldo time-
dependently increased ROS generation, and H2O2 (10
4 mol/L) application
remarkably elevated podocyte autophagy. After treatment with NAC, the
autophagy induced by Aldo or H2O2 was markedly attenuated, suggesting a
key role of ROS in mediating the autophagy formation in podocytes. Inhibi-
tion of ROS also could lessen Aldo-induced podocyte injury.
Conclusion: ROS-triggered autophagy played a protective role against Aldo-
induced podocyte injury, and targeting autophagy in podocytes may repre-
sent a new therapeutic strategy for the treatment of podocytopathy.http://dx.doi.org/10.1016/j.hkjn.2015.09.131
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Background: Emerging evidence suggested epithelial-mesenchymal transi-
tion (EMT) plays an essential role in the pathogenesis of renal tubulointersti-
tial fibrosis (TIF) which is the common pathway of end-stage renal failure
(ESRF). TGF-b1-induced EMT is a key contributor to fibrotic scar in diabetic
nephropathy by statistical analysis. Therefore, inhibition of EMT can be an
important therapeutic strategy to inhibit kidney fibrosis. Studies suggest
that peroxisome proliferator-activated receptor g (PPAR-g) agonists protect
kidney frbrosis in vivo and vitro which promote us to explore the effect on
TGF-b1-induced EMT.
Methods: Treatment with 10 ng/ml TGF-b1 for 3 days induced EMT. PPAR-g
agonists (Refine Gundam Zeta and 15-deoxyprostaglandin J2) or inhibitor
T007 were used to treat culture cells before the treatment of TGF-b1.
Changes in morphology were observed, expression of E-cadherin, snail anda-smooth muscle actin (a-SMA) were analyzed by western blot and real-
time PCR. We also used PPAR-g plasmid to transfect HK-2 cells.
Results: We firstly found that TGF-b1 lessened PPAR-g expression and activ-
ity in dose and time dependently manner, and activation of PPAR-g by RGZ
and 15d-PGJ2 prevents TGF-b-induced loss of E-cadherin expression and in-
hibits the induction of a-SMA and snail1, two typical marks involved in EMT.
Moreover, pretreated with antioxidant N-acetyl-L-cysteine, mitochondrial
respiratory chain complex I inhibitor rotenone (Rot) and NADPH oxidase in-
hibitor apocynin suggested that ROS mediated the inhibition of TGF-b1 on
PPAR-g expression and activity, and PPAR-g agonists blocked TGF-b1-
induced ROS production.
Conclusion: Based on these findings, we confirmed that activation of PPAR-g
by RGZ and 15d-PGJ2 or overexpression of PPAR-g protected TGF-b-induced
EMT via inhibition of ROS production suggesting that PPAR-g agonist might be
a new therapeutic target against kidney fibrosis.http://dx.doi.org/10.1016/j.hkjn.2015.09.132
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Objective: To investigate the presence of vitamin D receptor (VDR) and the
change of the main signaling pathway in 1,25-dihydroxyvitamin D3 (1,25(OH)
2D3) cultured human glomerular mesangial cells (HMC).
Methods: HMC cultured in vitro were randomly divided into two groups:
normal control group; 1,25(OH)2D3 (10e8 mol/L) group. VDR expression
was detected by real-time fluorescence quota PCR analysis, western-blot
and three parallel sets of monochromatic fluorescent cRNA micro-array. Be-
sides, the micro-array different genes chose by the 1.5-fold change stan-
dard, were analyzed by GO function classification, KEGG analysis and
pathway enrichment analysis.
Results: The expression of VDR in each group was not seen in the cellular
level. A small amount of VDR genes were detected in the cRNA micro-array
results. Micro-array data analysis indicated and confirmed that PI3K/AKT/
mTOR signaling pathway was inhibited and RAS pathway was activated.
Conclusion: Firstly, there has VDR in the HMC. The different results of the
cellular level may be caused by such two reasons: the amount of the VDR
in the HMC is very low or the RAS pathway inhibited the expression of the
VDR. Secondly, when 1,25(OH)2D3 cultured HMC, PI3K/AKT/mTOR signaling
pathway was inhibited and the RAS signaling pathway was activated.http://dx.doi.org/10.1016/j.hkjn.2015.09.133
0344
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Objective: Progressive tubulointerstitial fibrosis (TIF) is the final common
pathway leading to end stage renal disease. Tubular epithelial cells (TECs)
have a crucial role in the pathogenesis of TIF. The goal of the present study
was to examine the physiologic and pathologic role of Numb in kidney.
Methods: We examined the expression and distribution of Numb in normal
adult mouse kidney as well as in mouse model of renal fibrosis induced by
unilateral ureteral obstruction (UUO). To explore Numb’s role in renal
fibrosis, we generated a conditional knockout mouse model in which Numb
is selectively ablated from proximal tubules (PEPCK-Numb-KO). To confirm
the role of Numb in regulating cell cycle, Numb was overexpressed in
NRK52E cells by infecting with a Numb adenovirus (Ad-Numb) and endoge-
nous Numb was knocked down by siRNA in HK-2 cells before aristolochic
acid (AA) treatment. To examine the role of p53 in Numb-induced G2/M ar-
rest, Ad-Numb infected HK-2 cells were incubated with pifithrin-a, a p53
inhibitor.
S88 Inflammation and FibrosisResults: Numb is expressed in renal tubules and glomeruli. The expression of
Numb in renal tubules was significantly increased after UUO. After UUO,
PEPCK-Numb-KO mice exhibited significantly attenuated TIF. Ectopic expres-
sion of Numb increased the fraction of cells in G2/M stage and upregulated
the expression of TGF-b1 and CTGF in NRK52E cells. Knocking down endog-
enous Numb attenuated AA-induced G2/M arrest and profibrotic cytokines
production. Furthermore, G2/M arrest and expression of profibrotic cyto-
kines were significantly reduced in PEPCK-Numb-KO mice after UUO. Inhibit-
ing p53 activity dramatically mitigated Numb-induced G2/M arrest and
profibrotic cytokines production.
Conclusion: Numb has a profound effect on promoting G2/M arrest of TECs
through stabilizing p53 protein. Depletion of Numb markedly attenuates G2/
M arrest of proximal tubules which in turn reduces TIF. Numb might be a
novel therapeutic target for the treatment of tubulointerstitial fibrosis.http://dx.doi.org/10.1016/j.hkjn.2015.09.134
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Objective: Studies have shown that activation of peroxisome proliferator-
activated receptor-g (PPAR-g) ameliorates renal interstitial fibrosis (RIF) in
animal model. Yet, the underlying molecular mechanisms remain unknown.
Here, we investigated that activation of PPAR-g regulates renal remodeling
by modulating matrix metalloproteinases (MMPs) production in renal
fibroblasts.
Methods: In our present study, platelet-derived growth factor (PDGF) was
applied to stimulate renal fibroblasts, the inhibitor of PI3K or PTEN was
used to investigate the involvement of above mediators in MMPs production.
Results: Our results demonstrate that PDGF induced MMP2 secretion and this
effect was blocked by inhibition of PI3K. Pre-incubation of cells with rosigli-
tazone blocked PDGF-stimulated activation of AKT and PTEN and thus MMP2
production. Inhibition of PTEN by bpV (Pic) restored the suppression of PPAR-
g on AKT and MMP2.
Conclusion: Our results indicate that activation of PPAR-g inhibited MMP2
secretion by activation of PTEN and inactivation of AKT.http://dx.doi.org/10.1016/j.hkjn.2015.09.135
0349
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Background: Dyslipidemia is one of the risk factors contributing to the high
calcification burden in the arteries of CKD patients. However, the meta-
bolism by which lipids interact with mineral metabolism remains unknown.
We propose that Sterol Regulatory Element Binding Protein (SREBP) Cleavage
Activating Protein (SCAP), which is the central controller of lipid meta-
bolism, plays a role in VSMC calcification.
Methods: Calcium deposition was observed and colorimetrically analyzed by
Alizarin Red S staining and o-cresolphthalein complexone method. Theexpression of related genes and proteins were analyzed by real-time RT-
PCR and Western blotting methods. The co-expression of proteins was
observed by confocal microscope and flow cytometer. The influences of
calcifying medium and SCAP to VSMCs were investigated by TUNEL method,
wound scratch method and cell cycles analysis with PI staining.
Results: We demonstrated that phosphate markedly stimulated the
expression of SCAP in a dose dependent manner in human primary culture
of VSMC. We established a VSMC calcification model in vitro with 2.0 mM
phosphate and 2.7 mM calcium, in which SCAP expression was positively
associated with the expression of osteogenic marker/factor cbfa1. Over-
expression SCAP by pCMV-SCAP plasmid transfection led to more calcium
deposition, accompanying with up-regulated expression of osteogenic
markers cbfa1, BSP and ALP; and down-regulated expression of VSMC
maker a-SMA. These effects were blocked by knocking down SCAP by
applying siRNA against SCAP even in the presence of LPS which plays a
role as calcification inducer. Further, knocking-down SREBP2, a SCAP
target gene for lipid homeostasis did not affect SCAP induced calcium
deposition, suggesting that SCAP mediates phosphate induced vascular
calcification in a lipid independent pathway.
Conclusion: Our data strongly suggest that SCAP is a novel mediator of phos-
phate induced vascular calcification, and its pro-calcification effect is inde-
pendent of its traditional regulatory function in lipid metabolism.http://dx.doi.org/10.1016/j.hkjn.2015.09.136
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Objective: To explore HIF-1 on anemia of the 5/6 nephrectomy kidney of
rats with chronic renal failure.
Methods: SD rats were divided randomly into three groups: control group;
model group; and EPO group. From the 3rd week the EPO group was injected
of recombinant human EPO 40 IU/Kg, biw. The animals were sacrificed after
3 months, collecting blood and tissue samples of residual kidney. Renal pa-
thology was observed by HE stain. We examined HIF-1 protein by immunoflu-
orescence and Western blotting.
Results: (1) The rats renal function. Compared with the control group,
there were no significant changes in renal function in the control group af-
ter injection of EPO. (2) The renal pathological changes in residual renal
tissue. There were no significant changes in tubules, glomeruli and renal
interstitial in the control group. It appears segmental glomerular scle-
rosis, focal renal interstitial fibrosis and epithelial atrophy in the model
group. There were no significant changes in the control group after injec-
tion of EPO. (3) The changes of anemia. Compared with the control group,
the Hb of model group dropped 11.3 0.52 g/L. However, after subcu-
taneous injection of EPO, anemia improved, namely Hb 12.55 0.53 g/l.
(4) HIF-1 expression. Compared with the control group, HIF-1 nucleus pos-
itive was 28 1.32 in model group, and HIF-1 main shrinking expansion of
renal tubular epithelial cells. After injection of EPO, the expression of
HIF-1 was reduced, that HIF-1 nucleus positive expression of 20 1.48
(P <0.05).
Conclusion: HIF-1 expression can improve renal anemia in rats with chronic
renal failure.
